Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Lymphoma

  Free Subscription


5 Blood
3 Bone Marrow Transplant
1 Br J Dermatol
1 Br J Haematol
3 Haematologica
2 J Clin Oncol
1 Leuk Lymphoma
1 Oncogene

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. VOSE JM
    Peripheral T-cell lymphoma: novel backbone.
    Blood. 2018;131:375-376.
    PubMed     Text format    

  2. THAKRAL B, Konoplev S
    "Soccer ball" cells to "donut" cells: an unusual case of Richter syndrome.
    Blood. 2017;130:2358.
    PubMed     Text format    

  3. BATTISTELLA M, Leboeuf C, Ram-Wolff C, Hurabielle C, et al
    KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting.
    Blood. 2017;130:2900-2902.
    PubMed     Text format    

  4. FRIEDBERG JW, Forero-Torres A, Bordoni RE, Cline VJM, et al
    Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged >/=60 years with HL.
    Blood. 2017;130:2829-2837.
    PubMed     Text format     Abstract available

  5. CHONG EA, Melenhorst JJ, Lacey SF, Ambrose DE, et al
    PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR.
    Blood. 2017;129:1039-1041.
    PubMed     Text format    

    Bone Marrow Transplant

  6. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-017-0082.
    PubMed     Text format    

  7. JIMENEZ-UBIETO A, Grande C, Caballero D, Yanez L, et al
    Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-018-0096.
    PubMed     Text format    

  8. LAHOUD OB, Moskowitz AJ, Horwitz SM, Giralt SA, et al
    Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-017-0086.
    PubMed     Text format    

    Br J Dermatol

  9. KWATRA SG, Boozalis E, Kwatra MM
    Effects of neuroimmune axis modulation by aprepitant on anti-pruritic and global disease severity in patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16363.
    PubMed     Text format     Abstract available

    Br J Haematol

  10. HERSHKOVITZ-ROKAH O, Pulver D, Lenz G, Shpilberg O, et al
    Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects.
    Br J Haematol. 2018 Jan 23. doi: 10.1111/bjh.15108.
    PubMed     Text format     Abstract available


  11. FUJI S, Utsunomiya A, Inoue Y, Miyagi T, et al
    Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.
    Haematologica. 2018 Jan 25. pii: haematol.2017.184564.
    PubMed     Text format    

  12. LI Z, Ju X, Lee K, Clarke C, et al
    CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma.
    Haematologica. 2018 Jan 19. pii: haematol.2017.178384.
    PubMed     Text format     Abstract available

  13. VAN DEN NESTE E, Andre M, Gastinne T, Stamatoullas A, et al
    Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
    Haematologica. 2018 Jan 19. pii: haematol.2017.180554.
    PubMed     Text format     Abstract available

    J Clin Oncol

  14. GALLAMINI A, Tarella C, Viviani S, Rossi A, et al
    Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607
    J Clin Oncol. 2018 Jan 23:JCO2017752543. doi: 10.1200/JCO.2017.75.2543.
    PubMed     Text format     Abstract available

  15. SHADMAN M, Li H, Rimsza L, Leonard JP, et al
    Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus (131)I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.
    J Clin Oncol. 2018 Jan 22:JCO2017745083. doi: 10.1200/JCO.2017.74.5083.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  16. VILLA D, Sehn LH
    Double hit lymphoma: do we need a 'double hit' of intensive therapy?
    Leuk Lymphoma. 2018 Jan 25:1-2. doi: 10.1080/10428194.2018.1429606.
    PubMed     Text format    


  17. ESTEVE-ARENYS A, Valero JG, Chamorro-Jorganes A, Gonzalez D, et al
    The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.
    Oncogene. 2018 Jan 22. pii: 10.1038/s41388-017-0111.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.